Tax issues: comprehensive tax reform, deferral and transfer pricing.
Implementation of Budget Control Act of 2011 (Became PL 112-25 on 8-2-11).
Base erosion.
Budget issues, including Medicare Part D rebates and reductions in Medicare Part D low income subsidies. Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause" and Medicare Advantage. Independent Payment Advisory Board. Medicare and Entitlement Reform.
Low income subsidy co-pays.
H.R. 1407, Annual Drug User Fee Agreements of 2013.
Drug Quality and Security Act (Became P.L. 113-54 on 11/27/13).
Trans-Pacific Partnership. Biologic data exclusivity.
TTIP (US-EU trade bill). Trade promotion authority.
Trade with India.
Duration: January 1, 2008
to
December 31, 2013
General Issues: Taxation/Internal Revenue Code , Medicare/Medicaid , Health Issues , Trade (Domestic & Foreign) , Manufacturing , Pharmacy , Budget/Appropriations
Spending: about $1,170,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2008: House of Representatives, U.S. Senate,, U.S. Senate, Health & Human Services - Dept of (HHS), Executive Office of the President (EOP)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Kelly Bingel Chief of Staff, Sen. Blanche Lincoln
David Castagnetti Chief of Staff, Sen. Max Baucus
Karin Hudson Legislative Asst. Sen. Chris Dodd
Bruce Mehlman Asst. Sec. of Commerce for Tech Policy
Dean Rosen Health Policy Director, Sen. Frist
Elise Finley Pickering Chief of Staff, Rep. Shadegg; Exec. Dir. RPC
David Thomas Chief of Staff, Rep. Lofgren
Alex Vogel Chief Counsel, Sen. Frist
Allen Thompson Sr Prof Staff, House Cmte on Homeland Security
Stacey Rampy Legislative Dir., Rep Eshoo
Brian Wild Sr. Advisor, Office of Speaker John Boehner;
Dep. Assistant for Leg. Affairs, VP Cheney;
Chief of Staff, Rep. Pat Toomey;
Legislative Assistant, Sen. Hank Brown
Charles Wooters Chief of Staff, Rep. Chris Van Hollen; Director
of Member Services, Office of the Assistant to
the Speaker; Chief of Staff, Rep. Louise
Slaughter
Susan Stoner Legislative Assistant, Senator Crapo;
Legislative Assistant, Rep. Charlie Dent;
Legislative Correspondent, Rep. Tim Murphy;
Intern, Rep. Bill Shuster
Cynthia Brown Chief of Staff, Rep. Ron Kind
Legislative Assistant, Rep. Bart Stupak
Jonathan Hoganson Policy Director, House Democratic Caucus;
Legislative Director, Rep. Rahm Emanuel
Colette Desmarais Health Policy Advisor, Sen. Grassley
Jamie Brown Special Asst. to President for Leg. Affairs
Elise Pickering n/a
Jamie Brown Hantman (Brown) n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2013
MEHLMAN VOGEL CASTAGNETTI, INC. terminated an engagement in which they represented MERCK AND CO., INC. on Jan. 27, 2014.
Original Filing: 300629226.xml
Lobbying Issues
Tax issues: comprehensive tax reform, deferral and transfer pricing.
Implementation of Budget Control Act of 2011 (Became PL 112-25 on 8-2-11).
Base erosion.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Budget issues, including Medicare Part D rebates and reductions in Medicare Part D low income subsidies. Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause" and Medicare Advantage. Independent Payment Advisory Board. Medicare and Entitlement Reform.
Low income subsidy co-pays.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1407, Annual Drug User Fee Agreements of 2013.
Drug Quality and Security Act (Became P.L. 113-54 on 11/27/13).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Trans-Pacific Partnership. Biologic data exclusivity.
TTIP (US-EU trade bill). Trade promotion authority.
Trade with India.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
4th Quarter, 2013
In Q4, MEHLMAN VOGEL CASTAGNETTI, INC. lobbied for MERCK AND CO., INC. , earning $40,000. The report was filed on Jan. 22, 2014.
Original Filing: 300627277.xml
Lobbying Issues
Tax issues: comprehensive tax reform, deferral and transfer pricing.
Implementation of Budget Control Act of 2011 (Became PL 112-25 on 8-2-11).
Base erosion.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Budget issues, including Medicare Part D rebates and reductions in Medicare Part D low income subsidies. Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause" and Medicare Advantage. Independent Payment Advisory Board. Medicare and Entitlement Reform.
Low income subsidy co-pays.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1407, Annual Drug User Fee Agreements of 2013.
Drug Quality and Security Act (Became P.L. 113-54 on 11/27/13).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Trans-Pacific Partnership. Biologic data exclusivity.
TTIP (US-EU trade bill). Trade promotion authority.
Trade with India.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
3rd Quarter, 2013
In Q3, MEHLMAN VOGEL CASTAGNETTI, INC. lobbied for MERCK AND CO., INC. , earning $40,000. The report was filed on Oct. 16, 2013.
Original Filing: 300595014.xml
Lobbying Issues
Tax issues: comprehensive tax reform, deferral and transfer pricing.
Implementation of Budget Control Act of 2011 (Became PL 112-25 on 8-2-11).
Base erosion.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Budget issues, including Medicare Part D rebates and reductions in Medicare Part D low income subsidies. Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause" and Medicare Advantage. Independent Payment Advisory Board. Medicare and Entitlement Reform.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1407, Annual Drug User Fee Agreements of 2013.
H. 957, S. 959, H.R. 3204, H.R. 1919, Pharmaceutical Supply Chain Security.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Trans-Pacific Partnership. Biologic data exclusivity.
TTIP (US-EU trade bill). Trade promotion authority.
Trade with India.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
2nd Quarter, 2013
In Q2, MEHLMAN VOGEL CASTAGNETTI, INC. lobbied for MERCK AND CO., INC. , earning $50,000. The report was filed on July 19, 2013.
Original Filing: 300578767.xml
Lobbying Issues
Tax issues: comprehensive tax reform, deferral and transfer pricing.
Implementation of Budget Control Act of 2011 (Became PL 112-25 on 8-2-11).
Base erosion.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Budget issues, including Medicare Part D rebates and reductions in Medicare Part D low income subsidies. Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause" and Medicare Advantage. Independent Payment Advisory Board. Medicare and Entitlement Reform.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S. 957, Drug Supply chain Security Act.
H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013.
H.R. 1407, Annual Drug User Fee Agreements of 2013.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Trans-Pacific Partnership
Biologic data exclusivity
TTIP (US-EU trade bill)
Trade promotion authority
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
1st Quarter, 2013
In Q1, MEHLMAN VOGEL CASTAGNETTI, INC. lobbied for MERCK AND CO., INC. , earning $50,000. The report was filed on April 15, 2013.
Original Filing: 300550177.xml
Lobbying Issues
Tax issues: comprehensive tax reform, deferral and transfer pricing.
Implementation of Budget Control Act of 2011 (Became PL 112-25 on 8-2-11)
Base erosion
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Budget issues, including Medicare Part D rebates. Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause" and Medicare Advantage. Independent Payment Advisory Board.
Medicare and Entitlement Reform.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Prescription drug track and trace proposals.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Trans-Pacific Partnership
Biologic data exclusivity
TTIP (US-EU trade bill)
Trade promotion authority
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2012
In Q4, MEHLMAN VOGEL CASTAGNETTI, INC. lobbied for MERCK AND CO., INC. , earning $50,000. The report was filed on Jan. 15, 2013.
Original Filing: 300528798.xml
Lobbying Issues
Tax issues: comprehensive tax reform, deferral and transfer pricing.
Implementation of Budget Control Act of 2011 (Became PL 112-25 on 8-2-11)
H.R. 8, The American Taxpayer Relief Act of 2012
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Budget issues, including Medicare Part D rebates. Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause" and Medicare Advantage. Independent Payment Advisory Board.
Support efforts to ensure appropriate access to vaccines and preventive care. Medicare and Entitlement Reform.
H.R. 8, The American Taxpayer Relief Act of 2012
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Prescription drug track and trace provisions in:
The Food and Drug Administration Reform Act of 2012 (Became Public Law 110-85)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Permanent Normal Trade Relations with Russia.
Biologic data exclusivity in the Trans Pacific Partnership.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
3rd Quarter, 2012
In Q3, MEHLMAN VOGEL CASTAGNETTI, INC. lobbied for MERCK AND CO., INC. , earning $50,000. The report was filed on Oct. 15, 2012.
Original Filing: 300506531.xml
Lobbying Issues
Tax issues: comprehensive tax reform, deferral and transfer pricing.
Implementation of Budget Control Act of 2011 (Became PL 112-25 on 8-2-11)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Budget issues, including Medicare Part D rebates. Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause" and Medicare Advantage. Independent Payment Advisory Board.
Support efforts to ensure appropriate access to vaccines and preventive care.
Medicare and Entitlement Reform
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Prescription drug track and trace provisions in:
The Food and Drug Administration Reform Act of 2012 (Became Public Law 110-85)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Permanent Normal Trade Relations with Russia.
Biologic data exclusivity in the Trans Pacific Partnership.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
2nd Quarter, 2012
In Q2, MEHLMAN VOGEL CASTAGNETTI, INC. lobbied for MERCK AND CO., INC. , earning $50,000. The report was filed on July 17, 2012.
Original Filing: 300485803.xml
Lobbying Issues
Tax issues: comprehensive tax reform, deferral and transfer pricing.
Implementation of Budget Control Act of 2011 (Became PL 112-25 on 8-2-11)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Budget issues, including Medicare Part D rebates. Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause" and Medicare Advantage. Independent Payment Advisory Board.
Support efforts to ensure appropriate access to vaccines and preventive care.
Medicare and Entitlement Reform
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Prescription drug track and trace provisions in:
H.R. 5651, The Food and Drug Administration Reform Act of 2012.
S. 3187, The Food and Drug Administration Safety and Innovation Act.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2012
In Q1, MEHLMAN VOGEL CASTAGNETTI, INC. lobbied for MERCK AND CO., INC. , earning $50,000. The report was filed on April 18, 2012.
Original Filing: 300464185.xml
Lobbying Issues
Tax issues: comprehensive tax reform, deferral and transfer pricing.
Implementation of Budget Control Act of 2011 (Became PL 112-25 on 8-2-11)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Budget issues, including Medicare Part D rebates. Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause" and Medicare Advantage. Independent Payment Advisory Board.
Support efforts to ensure appropriate access to vaccines and preventive care.
H.R. 3630, The Middle Class Tax Relief and Job Creation Act of 2012 (Became PL 112-96 on 2/22/12).
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2011
In Q4, MEHLMAN VOGEL CASTAGNETTI, INC. lobbied for MERCK AND CO., INC. , earning $50,000. The report was filed on Jan. 17, 2012.
Original Filing: 300439316.xml
Lobbying Issues
Tax issues: comprehensive tax reform, deferral and transfer pricing.
Implementation of Budget Control Act of 2011 (Became PL 112-25 on 8-2-11)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Budget issues, including Medicare Part D rebates. Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause" and Medicare Advantage. Independent Payment Advisory Board.
Support efforts to ensure appropriate access to vaccines and preventive care.
Implementation of Budget Control Act of 2011 (Became PL 112-25 on August 2, 2011)
H.R. 3630, Temporary Payroll Tax Cut Continuation Act of 2011
H.R. 3765, Temporary Payroll Tax Cut Continuation Act of 2011 (Became PL 112-78 on 12-23-11)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3080, US-Korea Free Trade Agreement Implementation Act (Passed House and Senate on 10-12-11 and
became PL 112-41 on 10-21-11)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
3rd Quarter, 2011
In Q3, MEHLMAN VOGEL CASTAGNETTI, INC. lobbied for MERCK AND CO., INC. , earning $50,000. The report was filed on Oct. 17, 2011.
Original Filing: 300415209.xml
Lobbying Issues
Tax issues: comprehensive tax reform, deferral and transfer pricing.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Budget issues, including Medicare Part D rebates. Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause" and Medicare Advantage. Independent Payment Advisory Board.
Support efforts to ensure appropriate access to vaccines and preventive care.
Budget Control Act of 2011 (Became PL 112-25 on August 2, 2011)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Korea Free Trade Agreement
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
2nd Quarter, 2011
In Q2, MEHLMAN VOGEL CASTAGNETTI, INC. lobbied for MERCK AND CO., INC. , earning $50,000. The report was filed on July 15, 2011.
Original Filing: 300391068.xml
Lobbying Issues
Health Care Reform Implementation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Budget issues, including Medicare Part D rebates. Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause" and Medicare Advantage. Legislation to address physician payments issues, including SGR and related provisions to Medicare package. Health reform implementation. Independent Payment Advisory Board. Support efforts to ensure appropriate access to vaccines and preventive care.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Tax issues: comprehensive tax reform, deferral and transfer pricing.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Korea Free Trade Agreement
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
1st Quarter, 2011
In Q1, MEHLMAN VOGEL CASTAGNETTI, INC. lobbied for MERCK AND CO., INC. , earning $50,000. The report was filed on April 15, 2011.
Original Filing: 300364685.xml
Lobbying Issues
Health Care Reform Implementation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health Care Reform Implementation, Medicare reform, Medicaid payment. Support efforts to ensure appropriate access to vaccines and preventive care.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Tax issues: comprehensive tax reform, deferral and transfer pricing.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2010
In Q4, MEHLMAN VOGEL CASTAGNETTI, INC. lobbied for MERCK AND CO., INC. , earning $50,000. The report was filed on Jan. 19, 2011.
Original Filing: 300342717.xml
Lobbying Issues
Health Care Reform Implementation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health Care Reform Implementation, Medicare reform, Medicaid payment. Support efforts to ensure appropriate access to vaccines and preventive care.
H.R. 4994, Medicare and Medicaid Extenders Act of 2010 (Became PL-309 on 12/15/10)
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Tax issues, including deferral and transfer pricing.
H.R. 4853, Tax Relief, Unemployment Insurance Reauthorization and Job Creation Act of 2010 (Became PL 111-312 on 12/7/10)
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2010
In Q3, MEHLMAN VOGEL CASTAGNETTI, INC. lobbied for MERCK AND CO., INC. , earning $50,000. The report was filed on Oct. 19, 2010.
Original Filing: 300318752.xml
Lobbying Issues
Health Care Reform Implementation
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health Care Reform Implementation, Medicare reform, Medicaid payment. H.R. 4213, Unemployment Compensation Extension Act of 2010 (Became PL 111-205 on July 22, 2010). Support efforts to ensure appropriate access to vaccines and preventive care. Issues related to State Children's Health Insurance Program Coverage
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Tax issues, including deferral.
H.R. 5893, Investing in American Jobs and Closing Tax Loopholes Act of 2010
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2010
In Q2, MEHLMAN VOGEL CASTAGNETTI, INC. lobbied for MERCK AND CO., INC. , earning $50,000. The report was filed on July 19, 2010.
Original Filing: 300294183.xml
Lobbying Issues
Health Care Reform.
Awareness and treatment of viral hepatitis (S.Res. 531, h.Res. 466, H. Res. 1309, HR 3974)
H.R. 3590, Implementation of comparative effectiveness provisions of health care reform bill (H.R. 3590).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health Care Reform, Medicare reform, Medicaid payment.
H.R. 3962, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010
H.R. 4213, American Jobs and Closing Tax Loopholes Act of 2010
H.R. 4851, Continuing Extension Act of 2010
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Support efforts to ensure appropriate access to vaccines and preventive care. Issues related to Medicare, Medicaid, and State Children's Health Insurance Program Coverage. Issues related to The Implementation of the FDAAA of 2007. Issues relating to importation of prescription drugs.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Deferral and other foreign tax issues.
H.R. 4213, American Jobs and Closing Tax Loopholes Act of 2010
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2010
In Q1, MEHLMAN VOGEL CASTAGNETTI, INC. lobbied for MERCK AND CO., INC. , earning $50,000. The report was filed on April 20, 2010.
Original Filing: 300268379.xml
Lobbying Issues
Health Care Reform: S. 1796, America's Healthy Future Act of 2009; H.R. 3200, America's Affordable Health Choices Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act
Patient Access to Health Care; Access to Medicines; Expansion of Health Coverage. S.301, The Physician Payments Sunshine Act of 2009. H.R. 4872, The Health Care and Education Reconciliation Act of 2010
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health Care Reform: S. 1796, America's Healthy Future Act of 2009; H.R. 3200, America's Affordable Health Choices Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act
Patient Access to Health Care; Access to Medicines including vaccines; Expansion of Health Coverage. S.301, The Physician Payments Sunshine Act of 2009. H.R. 4872, The Health Care and Education Reconciliation Act of 2010
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Support efforts to ensure appropriate access to vaccines and preventive care. Issues related to Medicare, Medicaid, and State Children's Health Insurance Program Coverage. Issues related to The Implementation of the FDAAA of 2007. Issues relating to importation of prescription drugs.
S. 1796, America's Healthy Future Act of 2009
H.R. 3200, America's Affordable Health Choices Act of 2009
H.R. 3962, Affordable Health Care for America Act
H.R. 3590, Patient Protection and Affordable Care Act
H.R. 4872, The Health Care and Education Reconciliation Act of 2010
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Deferral and other foreign tax issues.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2009
In Q4, MEHLMAN VOGEL CASTAGNETTI, INC. lobbied for MERCK AND CO., INC. , earning $50,000. The report was filed on Jan. 15, 2010.
Original Filing: 300232927.xml
Lobbying Issues
Health Care Reform: S. 1796, America's Healthy Future Act of 2009; H.R. 3200, America's Affordable Health Choices Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act
Patient Access to Health Care; Access to Medicines; Expansion of Health Coverage.
S.301, The Physician Payments Sunshine Act of 2009.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health Care Reform: S. 1796, America's Healthy Future Act of 2009; H.R. 3200, America's Affordable Health Choices Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act
Patient Access to Health Care; Access to Medicines including vaccines; Expansion of Health Coverage.
S.301, The Physician Payments Sunshine Act of 2009.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Support efforts to ensure appropriate access to vaccines and preventive care. Issues related to Medicare, Medicaid, and State Children's Health Insurance Program Coverage. Issues related to The Implementation of the FDAAA of 2007. Issues relating to importation of prescription drugs.
S. 1796, America's Healthy Future Act of 2009
H.R. 3200, America's Affordable Health Choices Act of 2009
H.R. 3962, Affordable Health Care for America Act
H.R. 3590, Patient Protection and Affordable Care Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Deferral and other foreign tax issues.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2009
In Q3, MEHLMAN VOGEL CASTAGNETTI, INC. lobbied for MERCK AND CO., INC. , earning $50,000. The report was filed on Oct. 20, 2009.
Original Filing: 300215658.xml
Lobbying Issues
Health Care Reform: H.R.3200, America's Affordable Health Choices Act and S.1679, Affordable Health Choice Act
Patient Access to Health Care; Access to Medicines; Expansion of Health Coverage.
S.301, The Physician Payments Sunshine Act of 2009.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health Care Reform: H.R.3200, America's Affordable Health Choices Act and S.1679, Affordable Health Choices Act
Patient Access to Health Care; Access to Medicines including vaccines; Expansion of Health Coverage.
S.301, The Physician Payments Sunshine Act of 2009.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Support efforts to ensure appropriate access to vaccines and preventive care. Issues related to Medicare, Medicaid, and State Children's Health Insurance Program Coverage. Issues related to The Implementation of the FDAAA of 2007. Issues relating to importation of prescription drugs.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Deferral and other foreign tax issues.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2009
In Q2, MEHLMAN VOGEL CASTAGNETTI, INC. lobbied for MERCK AND CO., INC. , earning $50,000. The report was filed on July 13, 2009.
Original Filing: 300175937.xml
Lobbying Issues
Health Care Reform; Patient Access to Health Care; Access to Medicines; Expansion of Health Coverage.
S.301, The Physician Payments Sunshine Act of 2009.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Health Care Reform; Patient Access to Health Care; Access to Medicines including vaccines; Expansion of Health Coverage.
S.301, The Physician Payments Sunshine Act of 2009.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Support efforts to ensure appropriate access to vaccines and preventive care. Issues related to Medicare, Medicaid, and State Children's Health Insurance Program Coverage. Issues related to The Implementation of the FDAAA of 2007. Issues relating to importation of prescription drugs.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Deferral and other foreign tax issues.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2009
In Q1, MEHLMAN VOGEL CASTAGNETTI, INC. lobbied for MERCK AND CO., INC. , earning $50,000. The report was filed on April 20, 2009.
Original Filing: 300162742.xml
Lobbying Issues
Health Care Reform; Patient Access to Health Care; Access to Medicines; Expansion of Health Coverage
H.R.1, The American Recovery and Reinvestment Act of 2009; H.R.2, The Children's Health Insurance Program Extension
H.Con.Res.85, House Budget Resolution and S.Con.Res.13, Senate Budget Resolution
S.301, The Physician Payments Sunshine Act of 2009
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Medicaid
Lobbying Issues
Support efforts to ensure appropriate access to vaccines and preventive care. Issues related to Medicare, Medicaid, and State Children's Health Insurance Program Coverage. Issues related to The implementation of the FDAAA of 2007. Issues relating to importation of prescription drugs.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Deferral and Repatriation
H.R.1, The American Recovery and Reinvestment Act of 2009
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2008
In Q4, MEHLMAN VOGEL CASTAGNETTI, INC. lobbied for MERCK AND CO., INC. , earning $50,000. The report was filed on Jan. 16, 2009.
Original Filing: 300124264.xml
Lobbying Issues
Support efforts to ensure appropriate access to vaccines and preventive care. Issues related to Medicare, Medicaid, and State Children's Health Insurance Program Coverage. Issues related to The implementation of the FDAAA of 2007. Issues relating to importation of prescription drugs.Issues relating to Medicare and Medicaid coverage to treat and prevent diseases related to obesity.
S. 1082, Food and Drug Administration Revitalization Act
H.R. 2900, Food and Drug Administration Amendment Act of 2007
S. 3101, Medicare Improvements for Patients and Providers Act of 2008
S 3118, Preserving Access to Medicare Act of 2008
H.R. 6331, Medicare Improvements for Patients and Providers act of 2008
S. 2029, Physician Payments Sunshine Act of 2007
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Support efforts to ensure appropriate access to vaccines and preventive care. Issues related to Medicare, Medicaid, and State Children's Health Insurance Program Coverage. Issues related to The implementation of the FDAAA of 2007. Issues relating to importation of prescription drugs.Issues relating to Medicare and Medicaid coverage to treat and prevent diseases related to obesity.
S. 1082, Food and Drug Administration Revitalization Act
H.R. 2900, Food and Drug Administration Amendment Act of 2007
S. 3101, Medicare Improvements for Patients and Providers act of 2008
S 3118, Preserving Access to Medicare Act of 2008
H.R. 6331, Medicare Improvements for Patients and Providers act of 2008
S. 2029, Physician Payments Sunshine Act of 2007
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Support efforts to ensure appropriate access to vaccines and preventive care. Issues related to Medicare, Medicaid, and State Children's Health Insurance Program Coverage. Issues related to The implementation of the FDAAA of 2007. Issues relating to importation of prescription drugs.Issues relating to Medicare and Medicaid coverage to treat and prevent diseases related to obesity.
S.1082, Food and Drug Administration Revitalization Act
H.R. 2900, Food and Drug Administration Amendment Act of 2007
S.3101, Medicare Improvements for Patients and Providers act of 2008
S.3118, Preserving Access to Medicare Act of 2008
H.R.6331, Medicare Improvements for Patients and Providers act of 2008
S.2029, Physician Payments Sunshine Act of 2007
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2008
In Q3, MEHLMAN VOGEL CASTAGNETTI, INC. lobbied for MERCK AND CO., INC. , earning $50,000. The report was filed on Oct. 20, 2008.
Original Filing: 300103327.xml
Lobbying Issues
Support efforts to ensure appropriate access to vaccines and preventive care. Issues related to Medicare, Medicaid, and State Children's Health Insurance Program Coverage. Issues related to The implementation of the FDAAA of 2007. Issues relating to importation of prescription drugs.Issues relating to Medicare and Medicaid coverage to treat and prevent diseases related to obesity.
S. 1082, Food and Drug Administration Revitalization Act
H.R. 2900, Food and Drug Administration Amendment Act of 2007
S. 3101, Medicare Improvements for Patients and Providers Act of 2008
S 3118, Preserving Access to Medicare Act of 2008
H.R. 6331, Medicare Improvements for Patients and Providers act of 2008
S. 2029, Physician Payments Sunshine Act of 2007
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Support efforts to ensure appropriate access to vaccines and preventive care. Issues related to Medicare, Medicaid, and State Children's Health Insurance Program Coverage. Issues related to The implementation of the FDAAA of 2007. Issues relating to importation of prescription drugs.Issues relating to Medicare and Medicaid coverage to treat and prevent diseases related to obesity.
S. 1082, Food and Drug Administration Revitalization Act
H.R. 2900, Food and Drug Administration Amendment Act of 2007
S. 3101, Medicare Improvements for Patients and Providers act of 2008
S 3118, Preserving Access to Medicare Act of 2008
H.R. 6331, Medicare Improvements for Patients and Providers act of 2008
S. 2029, Physician Payments Sunshine Act of 2007
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Support efforts to ensure appropriate access to vaccines and preventive care. Issues related to Medicare, Medicaid, and State Children's Health Insurance Program Coverage. Issues related to The implementation of the FDAAA of 2007. Issues relating to importation of prescription drugs.Issues relating to Medicare and Medicaid coverage to treat and prevent diseases related to obesity.
S.1082, Food and Drug Administration Revitalization Act
H.R. 2900, Food and Drug Administration Amendment Act of 2007
S.3101, Medicare Improvements for Patients and Providers act of 2008
S.3118, Preserving Access to Medicare Act of 2008
H.R.6331, Medicare Improvements for Patients and Providers act of 2008
S.2029, Physician Payments Sunshine Act of 2007
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2008
In Q2, MEHLMAN VOGEL CASTAGNETTI, INC. lobbied for MERCK AND CO., INC. , earning $45,000. The report was filed on July 18, 2008.
Original Filing: 300074709.xml
Lobbying Issues
Support efforts to ensure appropriate access to vaccines under Medicare. Issues related to trade policy regarding Brazil. S. 1893 and H.R. 3163. Issues related to Medicare, Medicaid, and State Children's Health Insurance Program Coverage. Issues related to The implementation of the FDAAA of 2007 and drug safety, . Issues relating to importation of prescription drugs. Issues related to preventive benefits under Medicare.Issues relating to Medicare and Medicaid coverage to treate and parevent diseases related to obesity. S. 1082, H.R. 2900, S. 3101, S 3118, H.R. 6331, S. 2029.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Support efforts to ensure appropriate access to vaccines under Medicare. Issues related to trade policy regarding Brazil. S. 1893 and H.R. 3163. Issues related to Medicare, Medicaid, and State Children's Health Insurance Program Coverage. Issues related to the implementation of the FDAAA act of 2007 and drug safety. Issues relating to importation of prescription drugs. Issues related to preventive benefits under Medicare.Issues relating to Medicare and Medicaid coverage to treate and parevent diseases related to obesity. S. 1082, H.R. 2900, S. 3101, S 3118, H.R. 6331, S. 2029.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Support efforts to ensure appropriate access to vaccines under Medicare. Issues related to trade policy regarding Brazil. S. 1893 and H.R. 3163. Issues related to Medicare, Medicaid, and State Children's Health Insurance Program Coverage. Issues related to the implementation of the FDAAA act of 2007 and drug safety. Issues relating to importation of prescription drugs. Issues related to preventive benefits under Medicare.Issues relating to Medicare and Medicaid coverage to treate and parevent diseases related to obesity. S. 1082, H.R. 2900, S. 3101, S 3118, H.R. 6331, S. 2029
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2008
In Q1, MEHLMAN VOGEL CASTAGNETTI, INC. lobbied for MERCK AND CO., INC. , earning $45,000. The report was filed on April 21, 2008.
Original Filing: 300055425.xml
Lobbying Issues
Support efforts to ensure appropriate access to vaccines under Medicare. Issues related to trade policy regarding Brazil. S. 1893 and H.R. 3163. Issues related to Medicare, Medicaid, and State Children's Health Insurance Program Coverage. S. 1082 and H.R. 2900. Issues related to reauthorization of the Prescription Drug User Fee Act, drug safety, and reauthorization of the legislation regarding
pediatric drugs. Issues relating to importation of prescription drugs.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Medicaid
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...